Receptos to Present at Bank of America Merrill Lynch 2015 Healthcare Conference

| Source: Receptos, Inc. Receptos, Inc.

SAN DIEGO, May 7, 2015 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced that Faheem Hasnain, its President and Chief Executive Officer, will be presenting at the Bank of America Merrill Lynch 2015 Healthcare Conference at the Encore Hotel in Las Vegas, NV.   The presentation is scheduled for Wednesday, May 13th at 3:00pm Pacific time. 

About Receptos

Receptos is a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases. The Company's lead program, RPC1063, is a sphingosine 1-phosphate 1 and 5 receptor small molecule modulator in development for immune indications including relapsing multiple sclerosis and inflammatory bowel disease. Patents supporting RPC1063 were exclusively licensed to Receptos from The Scripps Research Institute (TSRI). The Company is also developing RPC4046, an anti-interleukin-13 (IL-13) antibody for eosinophilic esophagitis (EoE), an allergic/immune-mediated orphan disease.


            








        

            

                

                    
Tags

                            
                                BIOTECHNOLOGY
                            
                            
                                PHARMACEUTICALS
                            
                            
                                HEALTH
                            
                            
                                MEDICAL
                            

                



        




    

        

        
Contact Data